These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 36660710)
21. Construction and validation of senescence risk score signature as a novel biomarker in liver hepatocellular carcinoma: a bioinformatic analysis. Lai T; Li F; Xiang L; Liu Z; Li Q; Cao M; Sun J; Hu Y; Liu T; Liang J Transl Cancer Res; 2024 Sep; 13(9):4786-4799. PubMed ID: 39430830 [TBL] [Abstract][Full Text] [Related]
22. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma. He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852 [TBL] [Abstract][Full Text] [Related]
23. Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy. Cui Z; Liu C; Li H; Wang J; Li G Curr Med Chem; 2024 Feb; ():. PubMed ID: 38415454 [TBL] [Abstract][Full Text] [Related]
24. Vesicle-mediated transport-related genes predict the prognosis and immune microenvironment in hepatocellular carcinoma. Ye Z; Wang Y; Yuan R; Ding R; Hou Y; Qian L; Zhang S J Cancer; 2024; 15(12):3645-3662. PubMed ID: 38911369 [No Abstract] [Full Text] [Related]
25. An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma. Chen X; Sun M; Feng W; Chen J; Ji X; Xie M; Huang W; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L Front Genet; 2023; 14():1056000. PubMed ID: 36845390 [No Abstract] [Full Text] [Related]
26. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer. Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M Front Immunol; 2022; 13():891175. PubMed ID: 35990668 [TBL] [Abstract][Full Text] [Related]
27. The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma. Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; de Castria TB; Zeng B; Zong Z; Zhou T Ann Transl Med; 2022 Jul; 10(14):766. PubMed ID: 35965795 [TBL] [Abstract][Full Text] [Related]
28. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
29. Prognostic Role of ceRNA Network in Immune Infiltration of Hepatocellular Carcinoma. Xu Q; Chen S; Hu Y; Huang W Front Genet; 2021; 12():739975. PubMed ID: 34589117 [No Abstract] [Full Text] [Related]
30. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma. Jin C; Zhao JS; Huang XQ; Yang XZ; Niu FY; Lin JR; Ma L; Shi YX; Li XS; Jiang P; Gao S; Li F; Song Y Hepatol Int; 2022 Oct; 16(5):1220-1233. PubMed ID: 35947245 [TBL] [Abstract][Full Text] [Related]
31. Prognostic prediction and multidimensional dissections of a macrophages M0-related gene signature in liver cancer. Xu X; Wang J Front Endocrinol (Lausanne); 2023; 14():1153562. PubMed ID: 37033261 [TBL] [Abstract][Full Text] [Related]
32. A novel prognostic biomarker: Lai T; Peng T; Li J; Jiang Y; Liu K; Yu W; Yao N; Hu Y; Cao M; Liang J Transl Cancer Res; 2023 May; 12(5):1145-1164. PubMed ID: 37304536 [TBL] [Abstract][Full Text] [Related]
33. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response. Cao J; Liang Y; Gu JJ; Huang Y; Wang B Front Genet; 2022; 13():991162. PubMed ID: 36353118 [No Abstract] [Full Text] [Related]
34. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer. Pan Y; Zhang Q; Zhang H; Kong F Funct Integr Genomics; 2023 Jan; 23(1):38. PubMed ID: 36640225 [TBL] [Abstract][Full Text] [Related]
35. Exploring the Prognostic Significance and Immunotherapeutic Potential of Single-Cell Sequencing-Identified Long Noncoding RNA (LncRNA) in Patients With Non-small Cell Lung Cancer. Chen L; Wang L; Xiong Z; Zhu X; Chen L Cureus; 2023 Nov; 15(11):e48436. PubMed ID: 38074028 [TBL] [Abstract][Full Text] [Related]
36. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma. Bai Y; Lin H; Chen J; Wu Y; Yu S Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985 [No Abstract] [Full Text] [Related]
37. PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma. Zhao Q; Ye Y; Zhang Q; Wu Y; Wang G; Gui Z; Zhang M Biochem Biophys Rep; 2024 Mar; 37():101600. PubMed ID: 38371527 [TBL] [Abstract][Full Text] [Related]
38. Prognostic prediction using a gene signature developed based on exhausted T cells for liver cancer patients. Zhou Y; Wu W; Cai W; Zhang D; Zhang W; Luo Y; Cai F; Shi Z Heliyon; 2024 Mar; 10(6):e28156. PubMed ID: 38533068 [TBL] [Abstract][Full Text] [Related]
39. ER stress-related mRNA-lncRNA co-expression gene signature predicts the prognosis and immune implications of esophageal cancer. Li F; Ma J; Yan C; Qi Y Am J Transl Res; 2022; 14(11):8064-8084. PubMed ID: 36505280 [TBL] [Abstract][Full Text] [Related]
40. Identification of a DNA damage repair-related LncRNA signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma. Huang F; Zhang C; Yang W; Zhou Y; Yang Y; Yang X; Guo W; Wang B BMC Genomics; 2024 Feb; 25(1):155. PubMed ID: 38326754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]